Impax Global High Yield Euro 'B' Accumulation

Reference Data

ISIN IE000EM81116
Valor Number 136468726
Bloomberg Global ID
Fund Name Impax Global High Yield Euro 'B' Accumulation
Fund Provider Impax Asset Management Limited London, United Kingdom
Phone: +44 20 7432 2609
E-Mail: info@impax.co.uk
Web: www.impax.co.uk
Fund Provider Impax Asset Management Limited
Representative in Switzerland CACEIS Bank, Montrouge, Zurich Branch / Switzerland
Zurich
Phone: +41 44 405 97 00
Distributor(s)
Asset Class Bonds
EFC Category
Distribution Policy Accumulation
Home Country Ireland
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Fund's investment objective is to outperform the Benchmark and generate long term capital growth and income through an actively managed portfolio of predominantly global high yield securities.
Peculiarities

Fund Prices

Current Price * 1.06 EUR 03.07.2025
Previous Price * 1.06 EUR 02.07.2025
52 Week High * 1.06 EUR 03.07.2025
52 Week Low * 1.00 EUR 07.04.2025
NAV * 1.06 EUR 03.07.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 189,977,660
Unit/Share Assets *** 6,393
Trading Information SIX

Performance

YTD Performance +2.52% 31.12.2024
03.07.2025
YTD Performance (in CHF) +1.99% 31.12.2024
03.07.2025
1 month +1.44% 03.06.2025
03.07.2025
3 months +3.12% 03.04.2025
03.07.2025
6 months +2.42% 03.01.2025
03.07.2025
1 year +3.42% 31.10.2024
03.07.2025
2 years - -
3 years - -
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Electricite de France SA 1.96%
Sudzucker International Finance BV 5.95% 1.77%
Phoenix Group Holdings PLC 1.72%
Deutsche Bank Aktiengesellschaft, Frankfurt Branch 1.71%
Rothesay Life PLC 7.019% 1.68%
Millicom International Cellular SA 1.61%
CVS Health Corp 1.61%
Benteler International Aktiengesellschaft 1.60%
Centrica PLC 1.57%
Grifols S.A. 1.49%
Last data update 31.05.2025

Cost / Risk

TER
TER date
Performance Fee ***
PTR
Max. Management Fee *** 1.20%
Ongoing Charges ***
SRRI ***
SRRI date *** 30.06.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)